Acute effects of different intensities of exercise in normoalbuminuric/normotensive patients with type 1 diabetes.

OBJECTIVE The purpose of this study was to investigate the effect of exercise occurrence and intensity on albumin excretion in normotensive, normoalbuminuric patients with type 1 diabetes. RESEARCH DESIGN AND METHODS Eighteen patients (aged 29 +/- 2 years, duration of diabetes 14 +/- 2 years, blood pressure 120 +/- 2/74 +/- 1 mmHg, HbA(1c) 7.0 +/- 0.2% [mean +/- SE]) without microalbuminuria, hypertension, or anti-angiotensin II therapy participated in two exercise studies in a clinical research center. Exercise intensities were defined as moderate (50% heart rate reserve [HRR]) and intense (75% HRR) and were performed in random order. Subjects collected urine for albumin determination on the days before and after exercise. On the day of exercise, subjects exercised for 30 min on a treadmill at the assigned intensity. Timed urine collections were obtained over the day. Blood pressures were measured using an ambulatory blood pressure monitor. RESULTS Moderate exercise demonstrated no changes in albumin excretion. Intense exercise demonstrated a significant increase in albumin excretion during the first 4 h compared with the rest of the day (P = 0.03) but returned to normal thereafter. Albumin excretion did not exceed normal levels throughout the study. There was no difference in albumin excretion surrounding days of intense exercise. Ambulatory blood pressures demonstrated nocturnal dipping after moderate and intense exercise (P < 0.001). CONCLUSIONS We have demonstrated that normotensive, normoalbuminuric patients without anti-angiotensin II therapy do not have elevated albumin excretion following exercise intensities experienced by most patients with type 1 diabetes.

[1]  A. Timmis,et al.  Exercise tolerance testing , 2002, BMJ : British Medical Journal.

[2]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[3]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[4]  P. Poulsen,et al.  Lisinopril reduces albuminuria during exercise in low grade microalbuminuric Type 1 diabetic patients: a double blind randomized study , 2001, Journal of internal medicine.

[5]  P. Ebeling,et al.  Long-Term Lisinopril Therapy Reduces Exercise-Induced Albuminuria in Normoalbuminuric Normotensive IDDM Patients , 1998, Diabetes Care.

[6]  D. Swain,et al.  Relationship between % heart rate reserve and % VO2 reserve in treadmill exercise. , 1998, Medicine and science in sports and exercise.

[7]  N. Chaturvedi Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria , 1997, The Lancet.

[8]  D. Swain,et al.  Heart rate reserve is equivalent to %VO2 reserve, not to %VO2max. , 1997, Medicine and science in sports and exercise.

[9]  H. Parving,et al.  Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. , 1988, BMJ.

[10]  B. Feldt-Rasmussen,et al.  Exercise as a provocative test in early renal disease in Type 1 (insulin-dependent) diabetes: albuminuric, systemic and renal haemodynamic responses , 1985, Diabetologia.

[11]  C. Christensen Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise. , 1984, Kidney international.

[12]  C. Mogensen,et al.  Graded exercise and protein excretion in diabetic man and the effect of insulin treatment. , 1982, Kidney international.

[13]  C. Mogensen,et al.  Abnormal albumin excretion after two provocative renal tests in diabetes: physical exercise and lysine injection. , 1979, Kidney international.

[14]  C. W. Adams,et al.  The exercise tolerance test. , 1968, JAMA.

[15]  A. Kriska,et al.  Handbook of Exercise in Diabetes , 2004 .

[16]  Teven,et al.  EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .